Scientists at the University of Sydney have uncovered a malfunctioning version of the SOD1 protein that clumps inside brain ...

Groundbreaking research by Sydney University found a new brain protein involved in Parkinson’s disease and a way to modify it ...

Groundbreaking research by the University of Sydney has identified a new brain protein involved in the development of ...

Eight years after receiving a rare ALS diagnosis, a New Jersey mother credits an “amazing" new drug for stopping her disease in its tracks. She speaks to Fox News Digital about her experience.

Doctors are using a new gene therapy drug from the US, hoping to extend Ms Sabrina's lifespan. Read more at straitstimes.com. Read more at straitstimes.com.

The decision on the SOD1 ALS program does not impact Voyager’s other gene therapy programs; the Company continues to expect IND filings in 2025 from Neurocrine Biosciences for the program in ...

Binding with SOD1 may disrupt these functions, leading to neuron degeneration. It raises the question if addressing this interaction could slow or disrupt ALS progression, making septin-7 a ...

Treatments, studies and research are giving patients hope in 2024. And for the 2% of patients with the SOD1 gene, one new medication – Qalsody (tofersen) – is offering more hope than ever.

The disease, which is caused by mutations in the SOD1 gene, accounts for approximately 10% to 20% of genetic ALS cases and 1% to 2% of sporadic ALS cases, according to the ALS Association. 7.